Growth Metrics

Gilead Sciences (GILD) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $40.7 billion.

  • Gilead Sciences' Non-Current Assets rose 229.71% to $40.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $161.0 billion, marking a year-over-year decrease of 489.19%. This contributed to the annual value of $39.8 billion for FY2024, which is 1350.56% down from last year.
  • As of Q3 2025, Gilead Sciences' Non-Current Assets stood at $40.7 billion, which was up 229.71% from $41.0 billion recorded in Q2 2025.
  • Gilead Sciences' Non-Current Assets' 5-year high stood at $54.2 billion during Q1 2021, with a 5-year trough of $39.5 billion in Q1 2025.
  • Over the past 5 years, Gilead Sciences' median Non-Current Assets value was $48.1 billion (recorded in 2023), while the average stood at $46.6 billion.
  • As far as peak fluctuations go, Gilead Sciences' Non-Current Assets skyrocketed by 7730.7% in 2021, and later crashed by 1432.76% in 2024.
  • Over the past 5 years, Gilead Sciences' Non-Current Assets (Quarter) stood at $53.2 billion in 2021, then fell by 8.37% to $48.7 billion in 2022, then fell by 5.52% to $46.0 billion in 2023, then fell by 13.51% to $39.8 billion in 2024, then grew by 2.1% to $40.7 billion in 2025.
  • Its Non-Current Assets stands at $40.7 billion for Q3 2025, versus $41.0 billion for Q2 2025 and $39.5 billion for Q1 2025.